Finzati - Logo
ANIP logo

ANI Pharmaceuticals, Inc.

ANIPDrug Manufacturers - Specialty & Generic
$71.23
-0.76 (-1.06%)
Current price
EarningsLatest report: Jun 30, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Solid company profile with reasonable valuation support. The data suggests a balanced quality/value setup.
Market Cap
$1.78B
Growth
35.2%
Cash Flow
3/5
Trend
Mostly stable
Evidence
Positive revenue growth · 26.6%Positive free cash flow · 8.55Reasonable earnings multiple · 20.21Manageable debt level · 0.6Healthy liquidity · 2.71
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 9, 2026, 12:08 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$71.23
Change-1.06%
Market Cap$1.78B
52W Range70.15 - 99.50
Beta0.43
Gross Margin51.01%
Oper. Margin9.20%
Profit Margin8.87%
Debt/Eq0.60
Current Ratio2.71
Quick Ratio2.19
Revenue 5Y35.24%

Investment DNA

How strong this company looks for long-term investors

78
out of 100
Business Quality
Margins, moat, returns
61/100
Financial Strength
Debt, cash, stability
79/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
83/100
Why this score
Positive revenue growth · 26.6%Positive free cash flow · 8.55Reasonable earnings multiple · 20.21Manageable debt level · 0.6Healthy liquidity · 2.71

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-09
Low
$91.00
Mean
$91.00
Median
$91.00
High
$91.00

Company Overview

IPO: 5/5/2000
Industry: Drug Manufacturers - Specialty & Generic
P/B i: 2.93
Debt / Equity i: 0.60
Operating Margin: 9.20%
Net Margin: 8.87%
ROE i: -
ROIC: -

Financial Health

Score16 / 20
Debt / Equity: 0.60
Current Ratio: 2.71
Quick Ratio: 2.19
Status: Strong

Insider Transactions

Recent executive and insider activity

CAREY STEPHEN P.
Transaction: 07/29/2026
SELL
Change
-2,850
Price
$81.36
Filing
07/30/2026
Type
SELL
Cook Meredith
Transaction: 07/18/2026
SELL
Change
-2,466
Price
$79.20
Filing
07/21/2026
Type
SELL
Cook Meredith
Transaction: 07/13/2026
SELL
Change
-500
Price
$81.84
Filing
07/14/2026
Type
SELL